Participants received one of two approaches: bone marrow aspirate collected from the posterior iliac crest and combined with a scaffold, or standard treatment based on guided bone regeneration or an autogenous bone block graft. The experimental group contained 35 participants, while the standard-of-care group contained 29. The investigators used mixed models to compare outcomes between treatment groups. They also trained machine-learning models on extraction-socket and trauma or cleft-reconstruction datasets, then tested the models on trauma data to evaluate their ability to predict wound-healing index, quality of life, discomfort and whether adverse events occurred.

Discomfort increased across all groups over the four-week assessment period, indicating worsening symptoms after surgery; the change over time reached p < 0.001. The total quality-of-life score worsened with increasing age (p = 0.02). Hispanic participants recorded the highest overall quality-of-life scores (p = 0.01), while adverse events increased with age and among female participants (p < 0.001). These patterns describe associations within the analyzed population and do not establish causes. The analysis did not detect differences between the stem-cell and standard-care groups, supporting the authors’ conclusion that the two approaches had equivalent effects on the measured early outcomes.

Machine-learning approaches performed well in predicting the continuous outcomes of wound-healing index, quality of life and discomfort, particularly with nonlinear models. All tested models also predicted the binary outcome of adverse events. Together, the results suggest that computational models captured patterns in the postoperative outcome data. The analysis was limited to short-term assessments at one, two and four weeks, 64 participants pooled from three randomized studies, and several types of craniofacial procedure. As a secondary analysis of previously conducted trials, the work evaluated existing trial data rather than constituting a new randomized comparison of treatment effects.

Overall, the study found that experimental regenerative therapy did not produce detectable differences from established grafting approaches during early recovery after oral and craniofacial reconstruction. The findings support including patient-reported measures when evaluating these procedures, as the analysis evaluated recovery-related experiences in addition to wound-healing indicators. The results do not establish whether the treatments have equivalent long-term outcomes, implant success or tissue-regeneration benefits, and they cannot be extended beyond the four-week assessment period. The authors called for further research focused on patient-reported outcomes in oral and craniofacial reconstruction.

Subject of Research: Early patient-reported outcomes after experimental stem-cell therapy for craniofacial bone reconstruction

Article Title: Patient-reported outcomes following craniofacial regenerative stem cell therapy: a secondary analysis and machine learning approach

Article References: Almujaydil, R., Leow, N., Nguyen, L., Giannobile, W. V., D’Aiuto, F., & Kaigler, D. J. (2026). Patient-reported outcomes following craniofacial regenerative stem cell therapy: a secondary analysis and machine learning approach. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09106-w

Image Credits: AI Generated

DOI: 10.1186/s12967-026-09106-w

Keywords: stem-cell therapy, craniofacial reconstruction, patient-reported outcomes, wound healing, quality of life, bone grafting, machine learning, postoperative discomfort, adverse events, randomized trials, Patient-reported, outcomes

The historical arc described in the editorial is striking. Reconstructive surgery in its recognizable modern form largely emerged on the battlefields of the twentieth century, where military surgeons confronted injuries of a severity and volume rarely seen in civilian practice. The demands of trench warfare in the First World War drove the development of systematic techniques for facial reconstruction, skin grafting, and the management of complex wounds, and those wartime innovations seeded the civilian specialties that followed. Over the past hundred years, the editorial notes, numerous subspecialties and branches have emerged from that foundation, some widely known and others operating in relative obscurity, but all organized around a deeply personalized approach to treating the patient.

That diversification is one of the field’s defining technical characteristics. Today the umbrella of plastic and reconstructive surgery covers procedures as different in execution as they are in purpose. At one end sit aesthetic operations such as complex facelift procedures, where the surgical goal is refinement of appearance and the technical demands center on precision dissection, preservation of vascular supply, and predictable healing. At the other end sit oncological operations, including robot-assisted tumor resection, where robotic platforms offer magnified three-dimensional visualization and instruments with articulation beyond the capability of the human wrist, allowing surgeons to work within narrow anatomical corridors while planning immediate reconstruction of the resulting defects. Between these poles lie microsurgical free tissue transfer, craniofacial reconstruction, hand surgery, burn care, lymphatic surgery, and body contouring after massive weight loss, each with its own literature, complication profiles, and technical standards.

What unites them, according to the editorial, is a shared set of goals: to improve patient quality of life through surgical excellence, to minimize complications, and to apply innovative techniques and technologies on the basis of evidence rather than fashion. That formulation matters because the field has often been caricatured as driven by cosmetic demand, when in fact its core identity is reconstructive. The same principles of tissue handling, perfusion assessment, and wound management that govern a cosmetic procedure govern the reconstruction of a mandible after cancer resection or the closure of a complex abdominal wall defect. The editorial’s emphasis on evidence-driven innovation reflects a broader movement within surgery to subject even long-standing techniques to rigorous outcomes analysis.

The new journal’s editorial stance is explicitly inclusive. It states that it will welcome research that is scientifically valid and methodologically correct, regardless of how large or small the advance. This is a deliberate departure from the traditional model in which high-profile journals prioritize novelty, accepting landmark trials and rejecting incremental studies that nonetheless contain valuable data. The argument for inclusivity rests on the mathematics of evidence. Large-scale analyses, including systematic reviews and meta-analyses, depend on the aggregation of many individual findings, and the rare complications, unusual anatomical presentations, and negative results that never reach print are precisely the data points that clinical registries and pooled analyses need most.

The editorial develops this idea through an evocative analogy: a virtual conference in which researchers share findings and engage in discussion year-round, allowing others to view a single clinical scenario from tens or even hundreds of different perspectives. Such a platform, the editorial suggests, could educate better than any textbook and generate post-hoc data of extraordinary volume. The underlying concept is familiar from other domains of medicine, where multi-institutional collaborations have revealed patterns invisible to any single center. Surgical specialties have historically lagged in this respect, partly because operative technique varies so widely between surgeons and traditions, and partly because the specialty’s global distribution means that valuable experience is scattered across institutions with vastly different resources and publication access.

Removing barriers to that participation is central to the journal’s stated mission. The editorial commits to welcoming researchers without discrimination based on novelty, location, culture, financial capacity, or surgical tradition. Open access publishing plays a practical role here: when articles are freely readable from anywhere in the world, surgeons in settings without expensive journal subscriptions can both contribute to and draw upon the shared evidence base. The editorial argues that the next stage of progress in plastic and reconstructive surgery requires a worldwide approach, in which the community gathers data and findings collectively to enable the next impactful discovery. In an era when research is easily and openly accessible from anywhere, the journal positions itself as a platform for the accumulation of evidence and knowledge rather than a gatekeeper of prestige.

The scope of the new journal is correspondingly broad. It aims to accommodate all research historically tied to plastic and reconstructive surgery as well as new and developing areas directly related to the field. The subjects associated with the launch article hint at that breadth, spanning bone remodeling and targeted bone remodeling, regenerative medicine and tissue engineering, and surgical orthopedics, alongside core plastic surgery and reconstructive surgery topics. They also include a highly contemporary clinical challenge: complications in body contouring surgery after massive weight loss, an area that has grown dramatically as the population of patients undergoing bariatric procedures and, more recently, GLP-1 receptor agonist therapy has expanded, leaving a rising number of patients with excess tissue and distinct wound-healing risks.

The intersection with regenerative medicine and tissue engineering points to where much of the field’s technical future lies. Reconstructive surgeons have long depended on transferring the patient’s own tissue, and laboratory-grown alternatives, engineered scaffolds, and biologics that modulate healing promise to extend what reconstruction can achieve when native tissue is unavailable or insufficient. Similarly, the linkage with bone remodeling reflects the growing overlap between plastic surgery and skeletal reconstruction, where understanding of how bone responds to mechanical and biological cues informs everything from craniofacial advancement to the integration of implants. These adjacent disciplines are no longer peripheral; the editorial’s framing treats them as integral to the field’s identity.

For a specialty that began with improvised repairs under battlefield conditions, the trajectory described in the editorial is a measure of how far surgical medicine has come, and of how much of its progress now depends on infrastructure beyond the operating room. The launch of a dedicated, open access, inclusively edited journal is presented not as an end in itself but as a bet that the field’s next century of advances will be built on shared, pooled, globally contributed data rather than on isolated centers of excellence. Whether that bet pays off will depend on the community the journal attracts, but the premise is clear: the diversity that made plastic and reconstructive surgery unique is now the very reason it needs a common platform on which to record, compare, and learn from everything its practitioners do.

Subject of Research: The expansion of plastic and reconstructive surgery and the role of open access, multidisciplinary evidence sharing in the field

Article Title: Plastic and reconstructive surgery: a rapidly expanding field

Article References: Sinelnikov, M. Y. (2025). Plastic and reconstructive surgery: a rapidly expanding field. BMC Plastic and Reconstructive Surgery, 1(1), Article 1. https://doi.org/10.1186/s44452-025-00004-6

Image Credits: AI Generated

DOI: 10.1186/s44452-025-00004-6

Keywords: plastic surgery, reconstructive surgery, open access publishing, robot-assisted surgery, microsurgery, regenerative medicine, tissue engineering, bone remodeling, body contouring, evidence-based surgery, craniofacial reconstruction, global data sharing